PO-0732: First line low doses RT and chemoimmunotherapy in stage II/IV follicular lymphoma patients. (April 2018) - Galaverni, M.; Ciammella, P.; Renna, I.; Lattanzi, E.; Rosca, A.; Vigo, F.; Giaccherini, L.; Bellafiore, F.; Timon, G.; Galeandro, M.; Ruggieri, M.P.; Iotti, C.